Loading, please wait...
The Symposium is Free for HU and HUH Employees, Students, Adjunct Faculty and Preceptors.
~REGISTRATION IS REQUIRED FOR ALL ATTENDEES_VIRTUAL AND In-Person~ PLEASE NOTE Seating is LIMITED for In-Person Attendees so REGISTER NOW!
REGISTRATION FEE for Virtual Non-HU/HUH Attendees is $35////REGISTRATION Fee for Non-HU/HUH In-Person Attendees is $100
**LUNCH is Provided for REGISTERED In-Person Attendees ONLY**
Date: Apr 5, 2023 11:00 AM - 03:30 AM
Fee
$100.00
CE Hours
2.50
CE Units
0.250
Registration closes on Apr 30, 2023 10:00 PM
Activity Type
- Knowledge
Target Audience(s)
- CEOs and CFOs
- Faculty
- Fellows
- Insurance Companies
- Managed Care Consultants
- Patient Care Advocates
- Pharmacists
- Pharmacy Residents
- Physicians
- Researchers
Accreditation(s)
|
Accreditation Statement: Howard University College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
|
Joint Provider(s)
Academy of Managed Care Pharmacy (AMCP), Biologics & Biosimilars Collective Intelligence Consortium (BBCIC), and US Food and Drug Administration (FDA)
Support/Credits
The HU Biosimilars symposium was made possible due to a funding grant from Pfizer. However, Pfizer was not involved in any capacity in the planning, content, or the selection of speakers for this event. Furthermore, funds from the grant were not used for food and beverages.
|
Please choose a Fee Type from the Drop Down Menu Below:
I am a
|
Registration closes on Apr 30, 2023
at 10:00 PM
Registration closes on Apr 30, 2023
at 10:00 PM
Registration Closed
Registration Closed
Objectives
- Recognize the role of biosimilars in practice and their impact on access to treatment, cost of care, and patient outcomes.
- Identify currently available biosimilars and those expected to be approved in the next year and their impact on pharmacy practice.
- Explain the barriers to adoption and strategies to overcome these barriers.
- Describe the resources available for healthcare providers to learn more about biosimilar and interchangeable products.
- Describe and explain the key concepts of biologic products development
- Describe and explain FDA’s approach to the development of biosimilars
- Explain the use of biosimilar and interchangeable products in practice.
- Describe and explain the resources available for health care providers to learn more about biosimilar and interchangeable products through the enhanced Purple Book and other FDA educational resources.
Activity Number
0010-9999-23-015-L04-P
Date:
04/05/23
Time:
11:15 AM - 12:45 PM
CE Hours
1.50
Registration Closed
Registration Closed
Registration Closed
Objectives
- Outline the regulatory science program commitments, research priorities, goals, and objectives.
- • Describe and explain research that can improve the efficiency of biosimilar development and advance the development of interchangeable products and the regulatory impact.
- Describe and explain opportunities for research about biosimilar and interchangeable biosimilars and the grant management process.
- Outline research vignettes and describe the associated regulatory impact.
Activity Number
0010-9999-23-016-L04-P
Date:
04/05/23
Time:
02:15 PM - 03:15 PM
CE Hours
1.00
Registration Closed